Amedisys (NASDAQ: AMED) reappoints its former CEO who grew shareholder value by 4X during his prior tenure as CEOApr 26, 2024∙ PaidShareAmedisys (AMED) - January 31, 2023497KB ∙ PDF fileDownloadDownload This post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext